Clinical Trials Browser

Phase 3 × Skin Neoplasms × Nivolumab × Clear all

NCT05297565 2025-02-27

CheckMate-6GE

Phase 3 Completed

14 enrolled 8 charts

Melanoma, Skin Neoplasms

NCT04410445 2023-04-21

PIVOT-12

Phase 3 Terminated

765 enrolled 13 charts

Melanoma, Skin Neoplasms

NCT03329846 2021-07-09

An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma

Phase 3 Completed

20 enrolled 10 charts

Melanoma, Skin Neoplasms